Claudy Mullon

1.9k total citations
62 papers, 1.5k citations indexed

About

Claudy Mullon is a scholar working on Surgery, Nephrology and Hepatology. According to data from OpenAlex, Claudy Mullon has authored 62 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 18 papers in Nephrology and 11 papers in Hepatology. Recurrent topics in Claudy Mullon's work include Dialysis and Renal Disease Management (18 papers), Pancreatic function and diabetes (14 papers) and Organ Transplantation Techniques and Outcomes (10 papers). Claudy Mullon is often cited by papers focused on Dialysis and Renal Disease Management (18 papers), Pancreatic function and diabetes (14 papers) and Organ Transplantation Techniques and Outcomes (10 papers). Claudy Mullon collaborates with scholars based in United States, Spain and Belgium. Claudy Mullon's co-authors include Barry A. Solomon, Zorina Pitkin, Winston R. Hewitt, Achilles A. Demetriou, Jacek Rózga, Susumu Eguchi, John J. O’Neil, E. Kahaku, Theodore M. Khalili and N. Arkadopoulos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Biotechnology and Hepatology.

In The Last Decade

Claudy Mullon

61 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudy Mullon United States 20 1.1k 616 275 195 183 62 1.5k
Marie Felldin Sweden 20 1.4k 1.3× 137 0.2× 615 2.2× 250 1.3× 47 0.3× 43 1.8k
Alena Lodererová Czechia 18 387 0.4× 42 0.1× 84 0.3× 135 0.7× 103 0.6× 62 893
Carmine Panella Italy 16 482 0.4× 453 0.7× 101 0.4× 121 0.6× 14 0.1× 26 1.1k
Paul Atkison Canada 15 498 0.5× 141 0.2× 138 0.5× 184 0.9× 6 0.0× 32 879
Yoshihiro Ono Japan 17 260 0.2× 159 0.3× 107 0.4× 243 1.2× 6 0.0× 94 1.1k
Hiroyuki Tanaka Japan 20 188 0.2× 62 0.1× 81 0.3× 332 1.7× 80 0.4× 83 986
S. Schaffellner Austria 15 436 0.4× 202 0.3× 39 0.1× 41 0.2× 19 0.1× 58 630
Alexander H. Kirsch Austria 17 191 0.2× 29 0.0× 99 0.4× 174 0.9× 366 2.0× 55 1.1k
Takaaki Ohmori Japan 19 493 0.5× 114 0.2× 37 0.1× 216 1.1× 12 0.1× 98 1.2k
Zhiren Fu China 17 276 0.3× 313 0.5× 36 0.1× 266 1.4× 13 0.1× 63 934

Countries citing papers authored by Claudy Mullon

Since Specialization
Citations

This map shows the geographic impact of Claudy Mullon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudy Mullon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudy Mullon more than expected).

Fields of papers citing papers by Claudy Mullon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudy Mullon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudy Mullon. The network helps show where Claudy Mullon may publish in the future.

Co-authorship network of co-authors of Claudy Mullon

This figure shows the co-authorship network connecting the top 25 collaborators of Claudy Mullon. A scholar is included among the top collaborators of Claudy Mullon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudy Mullon. Claudy Mullon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalantar‐Zadeh, Kamyar, et al.. (2021). Slipping Through the Pores: Hypoalbuminemia and Albumin Loss During Hemodialysis. International Journal of Nephrology and Renovascular Disease. Volume 14. 11–21. 36 indexed citations
2.
3.
Ficociello, Linda, Meijiao Zhou, Claudy Mullon, Michael S. Anger, & Robert J. Kossmann. (2021). Effect of Citrate-Acidified Dialysate on Intact Parathyroid Hormone in Prevalent Hemodialysis Patients: A Matched Retrospective Cohort Study. International Journal of Nephrology and Renovascular Disease. Volume 14. 475–486. 2 indexed citations
4.
Steer, Dylan, et al.. (2020). Clinical Performance of the Optiflux® F160NR Dialyzer. Journal of the American Society of Nephrology. 31(10S). 817–817. 1 indexed citations
5.
Coyne, Daniel W., et al.. (2020). Sucroferric Oxyhydroxide in Maintenance Hemodialysis: A Retrospective, Comparative Cohort Study. Kidney Medicine. 2(3). 307–316. 7 indexed citations
6.
Kalantar‐Zadeh, Kamyar, Linda Ficociello, Nicolaos V. Athienites, et al.. (2019). Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study. BMC Nephrology. 20(1). 396–396. 9 indexed citations
7.
Ficociello, Linda, et al.. (2019). <p>Phosphate binder pill burden, adherence, and serum phosphorus control among hemodialysis patients converting to sucroferric oxyhydroxide</p>. International Journal of Nephrology and Renovascular Disease. Volume 12. 1–8. 19 indexed citations
8.
Brunelli, Steven M., Steven M. Wilson, Linda Ficociello, Claudy Mullon, & José A. Díaz-Buxó. (2015). A Comparison of Clinical Parameters and Outcomes over 1 Year in Home Hemodialysis Patients Using 2008K@home or NxStage System One. ASAIO Journal. 62(2). 182–189. 2 indexed citations
9.
Sibbel, Scott, Linda Ficociello, Michael D. Black, et al.. (2014). Effects of Crit-Line® Monitor Use on Patient Outcomes and Epoetin Alfa Dosing following Onset of Hemodialysis: A Propensity Score-Matched Study. Blood Purification. 37(3). 249–257. 2 indexed citations
10.
Ofsthun, Norma J., et al.. (2011). Anemia Management in Patients Receiving Chronic Hemodialysis. Seminars in Dialysis. 24(5). 597–602. 8 indexed citations
11.
Wijkstrom, Martin, Norma S. Kenyon, Nicole Kirchhof, et al.. (2004). Islet allograft survival in nonhuman primates immunosuppressed with basiliximab, RAD, and FTY7201. Transplantation. 77(6). 827–835. 60 indexed citations
12.
McLaughlin, Brian, et al.. (1999). Overview of Extracorporeal Liver Support Systems and Clinical Results. Annals of the New York Academy of Sciences. 875(1). 310–325. 49 indexed citations
13.
Detry, Olivier, et al.. (1998). Bioartificial liver treatment of acetaminophen-induced fulminant hepatic failure. Open Repository and Bibliography (University of Liège). 4 indexed citations
14.
Mullon, Claudy, et al.. (1998). Oxygen Delivery to and Use by Primary Porcine Hepatocytes in the HepatAssist™ 2000 System for Extracorporeal Treatment of Patients in End-Stage Liver Failure. Advances in experimental medicine and biology. 454. 261–271. 17 indexed citations
15.
Watanabe, F., Claudy Mullon, Winston R. Hewitt, et al.. (1997). Clinical Experience With a Bioartificial Liver in the Treatment of Severe Liver Failure. Annals of Surgery. 225(5). 484–494. 365 indexed citations
16.
Mullon, Claudy, E. Kahaku, Winston R. Hewitt, et al.. (1997). Treatment of Severe Liver Failure with a Bioartificial Livera. Annals of the New York Academy of Sciences. 831(1). 350–360. 56 indexed citations
17.
Jauregui, Hugo O., et al.. (1995). In vivo evaluation of a hollow fiber liver assist device. Hepatology. 21(2). 460–469. 71 indexed citations
18.
Mullon, Claudy, et al.. (1992). Oral Treatment for Jaundice Using Immobilized Bilirubin Oxidase. Artificial Organs. 16(4). 331–335. 9 indexed citations
19.
Mullon, Claudy, et al.. (1988). The influence of bond chemistry on immobilized enzyme systems for ex vivo use. Biotechnology and Bioengineering. 32(4). 554–563. 12 indexed citations
20.
Mullon, Claudy, et al.. (1987). Forced‐flow electrophoresis of proteins and viruses. Biotechnology and Bioengineering. 30(1). 123–137. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026